We are live on ! Find out more
RGNX icon

Regenxbio
RGNX

177 hedge funds and large institutions have $1.87B invested in Regenxbio in 2018 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 51 increasing their positions, 33 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

252% more first-time investments, than exits

New positions opened: 81 | Existing positions closed: 23

180% more capital invested

Capital invested by funds: $668M → $1.87B (+$1.2B)

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

55% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 33

48% more funds holding

Funds holding: 120 → 177 (+57)

44% more call options, than puts

Call options by funds: $15.3M | Put options by funds: $10.6M

10.83% more ownership

Funds ownership: 70.66% → 81.49% (+11%)

Holders
177
Holders Change
+57
Holders Change %
+47.5%
% of All Funds
4.05%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
81
Increased
51
Reduced
33
Closed
23
Calls
$15.3M
Puts
$10.6M
Net Calls
+$4.7M
Net Calls Change
+$3.73M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$95.4M
2
WM
WS Management
Florida
+$40.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$27.4M
4
Wellington Management Group
Wellington Management Group
Massachusetts
+$20.8M
5
HCM
Highline Capital Management
New York
+$16.7M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$35.6M
2
RG
Redmile Group
California
-$27.2M
3
PHS
PFM Health Sciences
California
-$23.7M
4
JP Morgan Chase
JP Morgan Chase
New York
-$19M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$18.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJA
76
Raymond James & Associates
Florida
$1.61M +$1.07M +22,493 New
AIG
77
American International Group
New York
$1.56M +$193K +4,038 +23%
Manulife (Manufacturers Life Insurance)
78
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.52M +$10K +210 +1%
California Public Employees Retirement System
79
California Public Employees Retirement System
California
$1.45M +$962K +20,139 New
Lazard Asset Management
80
Lazard Asset Management
New York
$1.36M +$904K +18,932 New
SO
81
STRS Ohio
Ohio
$1.35M +$220K +4,600 +32%
Dimensional Fund Advisors
82
Dimensional Fund Advisors
Texas
$1.33M +$887K +18,571 New
State of Tennessee, Department of Treasury
83
State of Tennessee, Department of Treasury
Tennessee
$1.33M +$885K +18,537 New
Thrivent Financial for Lutherans
84
Thrivent Financial for Lutherans
Minnesota
$1.32M +$879K +18,403 New
ProShare Advisors
85
ProShare Advisors
Maryland
$1.29M +$4.54K +95 +0.5%
TRSOTSOK
86
Teachers Retirement System of the State of Kentucky
Kentucky
$1.29M +$862K +18,050 New
DCM
87
Dupont Capital Management
Delaware
$1.29M +$860K +18,003 New
GCP
88
GSA Capital Partners
United Kingdom
$1.28M +$854K +17,888 New
Barclays
89
Barclays
United Kingdom
$1.28M -$126K -2,637 -13%
Public Sector Pension Investment Board (PSP Investments)
90
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.25M +$831K +17,400 New
TPSF
91
Texas Permanent School Fund
Texas
$1.21M +$802K +16,789 New
ACM
92
Asymmetry Capital Management
California
$1.2M +$32.7K +684 +4%
American Century Companies
93
American Century Companies
Missouri
$1.11M +$740K +15,504 New
State Board of Administration of Florida Retirement System
94
State Board of Administration of Florida Retirement System
Florida
$1.08M +$155K +3,250 +28%
AS
95
Altshuler Shaham
Israel
$1.06M -$382K -8,000 -35%
VEA
96
Virtus ETF Advisers
New York
$1.04M -$576K -12,068 -45%
Millennium Management
97
Millennium Management
New York
$997K -$10.4M -216,935 -94%
TD Asset Management
98
TD Asset Management
Ontario, Canada
$976K +$129K +2,700 +25%
MIM
99
MetLife Investment Management
New Jersey
$948K – – –
FAM
100
Fred Alger Management
New York
$933K +$621K +13,000 New
2 3
4
5 6

RGNX Hedge Fund Activity: Q2 2018 in Review

177 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q2 2018, worth a combined $1.87B — up 180% from $668M a quarter earlier.

Buyers outnumbered sellers: 81 funds opened new RGNX positions and 23 closed out — a net gain of 58 holders — while 51 added to existing stakes and 33 trimmed.

The largest buyer was BlackRock, adding an estimated $95.4M. The largest seller was Citadel Advisors, cutting an estimated $35.6M.

  • 177 institutional investors held Regenxbio (RGNX) as of Q2 2018, up from 120 in Q1 2018.
  • Funds reported $1.87B of Regenxbio stock for Q2 2018, up 180% quarter-over-quarter.
  • 81 funds opened new Regenxbio positions in Q2 2018 and 23 closed out, a net change of +58 holders.
  • The largest Regenxbio buyer in Q2 2018 was BlackRock, an estimated $95.4M added.
  • The largest Regenxbio seller in Q2 2018 was Citadel Advisors, an estimated $35.6M sold.

Based on aggregated 13F filings for Q2 2018.